arrow
D

Dragomir B. Krastev

The Institute of Cancer Research
H指数:18
被引数:3,035

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A genome-scale adaptation map identifies the FANCM-RMI1/2 complex as an opposing modulator of cell fitness upon BRCA1 or BRCA2 loss

基因组规模适应性图谱鉴定FANCM-RMI1/2复合物为BRCA1或BRCA2缺失时细胞适应性的拮抗调节因子

2026-10-060
OAAI
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer

PUM3是同源重组缺陷型乳腺癌中复制应激所必需的抑制因子

2026-09-210
OAAI
The anion channel GPR89 is a tumor-specific dependency in breast cancer

GPR89阴离子通道是乳腺癌的肿瘤特异性依赖

2026-08-240
OA
Mitotic single-stranded DNA suppression by DDIAS

DDIAS介导的有丝分裂单链DNA抑制

2026-08-240
PRE
Nucleophagy removes cytotoxic trapped PARP1

核质吞噬清除细胞毒性被困的PARP1

2026-06-020
OAAI
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors

肿瘤特异性HORMAD1表达扰乱有丝分裂停滞并驱动对有丝分裂激酶抑制剂的敏感性

2026-03-110
OAAI
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers
2025-07-290
OAAI
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models

PARP抑制剂talazoparib与呼肠孤病毒协同作用,在小鼠模型中体内诱导癌症杀伤和肿瘤控制

2025-07-080
OAAI
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma

PPP2R1A突变导致卵巢透明细胞癌对ATR抑制剂的敏感性。

2025-02-121
OA
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells

MND1和PSMC3IP控制有丝分裂细胞的PARP抑制剂敏感性

2023-05-013
OA
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2022-10-237
OAAI
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

泛素依赖性ATPase p97从染色质中去除细胞毒性捕获的PARP1

2022-01-1087
OAAI